Bottom line
How much do IBRN and SBIO overlap?
24% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 26.4% of IBRN's assets and 16.8% of SBIO's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBRN and SBIO have in common
| Holding | % of IBRN | % of SBIO | Overlap |
|---|---|---|---|
| Dianthus Therapeutics Inc | 5.34% | 2.64% | 2.64% |
| Xenon Pharmaceuticals Inc | 4.87% | 2.90% | 2.90% |
| Acadia Pharmaceuticals Inc. | 4.69% | 2.35% | 2.35% |
| Alkermes Public Limited Company | 4.60% | 4.48% | 4.48% |
| Denali Therapeutics Inc | 3.67% | 2.13% | 2.13% |
| Edgewise Therapeutics Inc | 3.23% | 2.33% | 2.33% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBRN
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 14.64%
- Praxis Precision Medicines Inc — 4.87%
- Arrowhead Pharmaceuticals, Inc. — 4.65%
- Scholar Rock Holding Corp — 4.29%
- Biogen Inc. — 4.18%
- Neurocrine Biosciences, Inc. — 4.09%
- argenx SE — 3.86%
- Ptc Therapeutics, Inc. — 3.85%
- Axsome Therapeutics, Inc. — 3.77%
- Dyne Therapeutics, Inc — 3.56%
- Supernus Pharmaceuticals, Inc. — 2.61%
- AxoGen, Inc. — 2.34%
- SK Biopharmaceuticals Co Ltd — 2.30%
- H. Lundbeck A/s — 1.84%
- Biohaven Ltd — 1.82%
Only in SBIO
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Travere Therapeutics Inc — 2.77%
- Newamsterdam Pharma Co Nv — 2.47%
- Viking Therapeutics Inc — 2.41%
- Crinetics Pharmaceuticals Inc — 2.37%
- Oruka Therapeutics Inc — 1.81%
- Structure Therapeutics Inc — 1.78%
- Disc Medicine Inc — 1.69%
- Ideaya Biosciences Inc — 1.65%
- Vera Therapeutics Inc — 1.61%
Asset mix
| Asset type | IBRN | SBIO |
|---|---|---|
| Stocks | 95.5% | 100.0% |
| Cash & short-term funds | 14.8% | — |
| Other | 4.4% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | IBRN | SBIO |
|---|---|---|
| US | 85.2% | 80.2% |
| CA | 5.5% | 2.9% |
| IE | 5.0% | 4.5% |
| NL | 3.9% | 4.7% |
| KY | — | 4.7% |
| KR | 2.4% | — |
| SE | 2.4% | — |
| CH | 1.8% | 0.8% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do IBRN and SBIO overlap?
What stocks do IBRN and SBIO have in common?
Should I own both IBRN and SBIO?
Which holds more stocks, IBRN or SBIO?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.